Global Parkinson's Disease Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Global Parkinson's Disease Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Parkinson's Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinson's Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinson's Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Overview of Global Parkinson's Disease Drug Market
1.4.1 Global Parkinson's Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin Pharma
2.2.1 Kyowa Hakko Kirin Pharma Details
2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
2.2.4 Kyowa Hakko Kirin Pharma Product and Services
2.2.5 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Akorn
2.4.1 Akorn Details
2.4.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Akorn SWOT Analysis
2.4.4 Akorn Product and Services
2.4.5 Akorn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbvie SWOT Analysis
2.5.4 Abbvie Product and Services
2.5.5 Abbvie Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Desitin Arzneimittel
2.7.1 Desitin Arzneimittel Details
2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Desitin Arzneimittel SWOT Analysis
2.7.4 Desitin Arzneimittel Product and Services
2.7.5 Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical SWOT Analysis
2.8.4 Teva Pharmaceutical Product and Services
2.8.5 Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astellas Pharma
2.10.1 Astellas Pharma Details
2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astellas Pharma SWOT Analysis
2.10.4 Astellas Pharma Product and Services
2.10.5 Astellas Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apokyn
2.11.1 Apokyn Details
2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apokyn SWOT Analysis
2.11.4 Apokyn Product and Services
2.11.5 Apokyn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 US WorldMeds
2.12.1 US WorldMeds Details
2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 US WorldMeds SWOT Analysis
2.12.4 US WorldMeds Product and Services
2.12.5 US WorldMeds Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo Pharmaceuticals SWOT Analysis
2.13.4 Endo Pharmaceuticals Product and Services
2.13.5 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Orion
2.14.1 Orion Details
2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Orion SWOT Analysis
2.14.4 Orion Product and Services
2.14.5 Orion Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Valeant
2.15.1 Valeant Details
2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Valeant SWOT Analysis
2.15.4 Valeant Product and Services
2.15.5 Valeant Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 F.Hoffmann-La Roche
2.16.1 F.Hoffmann-La Roche Details
2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 F.Hoffmann-La Roche SWOT Analysis
2.16.4 F.Hoffmann-La Roche Product and Services
2.16.5 F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bausch Health
2.17.1 Bausch Health Details
2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bausch Health SWOT Analysis
2.17.4 Bausch Health Product and Services
2.17.5 Bausch Health Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Stada Arzneimittel
2.18.1 Stada Arzneimittel Details
2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Stada Arzneimittel SWOT Analysis
2.18.4 Stada Arzneimittel Product and Services
2.18.5 Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 H.Lundbeck
2.19.1 H.Lundbeck Details
2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 H.Lundbeck SWOT Analysis
2.19.4 H.Lundbeck Product and Services
2.19.5 H.Lundbeck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parkinson's Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parkinson's Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson's Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Parkinson's Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parkinson's Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson's Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parkinson's Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parkinson's Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Parkinson's Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Parkinson's Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parkinson's Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Parkinson's Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parkinson's Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parkinson's Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parkinson's Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parkinson's Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parkinson's Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Parkinson's Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Parkinson's Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parkinson's Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parkinson's Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parkinson's Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parkinson's Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Parkinson's Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Parkinson's Disease Drug Price by Type (2015-2020)
11 Global Parkinson's Disease Drug Market Segment by Application
11.1 Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Parkinson's Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Parkinson's Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parkinson's Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Parkinson's Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Parkinson's Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Parkinson's Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parkinson's Disease Drug Market Forecast (2021-2025)
12.2.4 South America Parkinson's Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parkinson's Disease Drug Market Forecast (2021-2025)
12.3 Parkinson's Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Parkinson's Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Parkinson's Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Parkinson's Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Parkinson's Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Parkinson's Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Parkinson's Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson's Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Parkinson's Disease Drug Major Business
Table 9. Merck Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Parkinson's Disease Drug Product and Services
Table 12. Merck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Major Business
Table 15. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 16. Kyowa Hakko Kirin Pharma SWOT Analysis
Table 17. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product and Services
Table 18. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Parkinson's Disease Drug Major Business
Table 21. Novartis Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Parkinson's Disease Drug Product and Services
Table 24. Novartis Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Akorn Basic Information, Manufacturing Base and Competitors
Table 26. Akorn Parkinson's Disease Drug Major Business
Table 27. Akorn Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 28. Akorn SWOT Analysis
Table 29. Akorn Parkinson's Disease Drug Product and Services
Table 30. Akorn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abbvie Basic Information, Manufacturing Base and Competitors
Table 32. Abbvie Parkinson's Disease Drug Major Business
Table 33. Abbvie Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 34. Abbvie SWOT Analysis
Table 35. Abbvie Parkinson's Disease Drug Product and Services
Table 36. Abbvie Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GSK Basic Information, Manufacturing Base and Competitors
Table 38. GSK Parkinson's Disease Drug Major Business
Table 39. GSK Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 40. GSK SWOT Analysis
Table 41. GSK Parkinson's Disease Drug Product and Services
Table 42. GSK Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Desitin Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 44. Desitin Arzneimittel Parkinson's Disease Drug Major Business
Table 45. Desitin Arzneimittel Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 46. Desitin Arzneimittel SWOT Analysis
Table 47. Desitin Arzneimittel Parkinson's Disease Drug Product and Services
Table 48. Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Parkinson's Disease Drug Major Business
Table 51. Teva Pharmaceutical Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 52. Teva Pharmaceutical SWOT Analysis
Table 53. Teva Pharmaceutical Parkinson's Disease Drug Product and Services
Table 54. Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 56. Boehringer Ingelheim Parkinson's Disease Drug Major Business
Table 57. Boehringer Ingelheim Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 58. Boehringer Ingelheim SWOT Analysis
Table 59. Boehringer Ingelheim Parkinson's Disease Drug Product and Services
Table 60. Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Astellas Pharma Parkinson's Disease Drug Major Business
Table 63. Astellas Pharma Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 64. Astellas Pharma SWOT Analysis
Table 65. Astellas Pharma Parkinson's Disease Drug Product and Services
Table 66. Astellas Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Apokyn Basic Information, Manufacturing Base and Competitors
Table 68. Apokyn Parkinson's Disease Drug Major Business
Table 69. Apokyn Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 70. Apokyn SWOT Analysis
Table 71. Apokyn Parkinson's Disease Drug Product and Services
Table 72. Apokyn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. US WorldMeds Basic Information, Manufacturing Base and Competitors
Table 74. US WorldMeds Parkinson's Disease Drug Major Business
Table 75. US WorldMeds Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 76. US WorldMeds SWOT Analysis
Table 77. US WorldMeds Parkinson's Disease Drug Product and Services
Table 78. US WorldMeds Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Endo Pharmaceuticals Parkinson's Disease Drug Major Business
Table 81. Endo Pharmaceuticals Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 82. Endo Pharmaceuticals SWOT Analysis
Table 83. Endo Pharmaceuticals Parkinson's Disease Drug Product and Services
Table 84. Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Orion Basic Information, Manufacturing Base and Competitors
Table 86. Orion Parkinson's Disease Drug Major Business
Table 87. Orion Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 88. Orion SWOT Analysis
Table 89. Orion Parkinson's Disease Drug Product and Services
Table 90. Orion Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Valeant Basic Information, Manufacturing Base and Competitors
Table 92. Valeant Parkinson's Disease Drug Major Business
Table 93. Valeant Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 94. Valeant SWOT Analysis
Table 95. Valeant Parkinson's Disease Drug Product and Services
Table 96. Valeant Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. F.Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 98. F.Hoffmann-La Roche Parkinson's Disease Drug Major Business
Table 99. F.Hoffmann-La Roche Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 100. F.Hoffmann-La Roche SWOT Analysis
Table 101. F.Hoffmann-La Roche Parkinson's Disease Drug Product and Services
Table 102. F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 104. Bausch Health Parkinson's Disease Drug Major Business
Table 105. Bausch Health Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 106. Bausch Health SWOT Analysis
Table 107. Bausch Health Parkinson's Disease Drug Product and Services
Table 108. Bausch Health Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Stada Arzneimittel Parkinson's Disease Drug Type and Application
Table 110. Stada Arzneimittel Parkinson's Disease Drug Major Business
Table 111. Stada Arzneimittel Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 112. Stada Arzneimittel SWOT Analysis
Table 113. Stada Arzneimittel Parkinson's Disease Drug Product and Services
Table 114. Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. H.Lundbeck Basic Information, Manufacturing Base and Competitors
Table 116. H.Lundbeck Parkinson's Disease Drug Major Business
Table 117. H.Lundbeck Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 118. H.Lundbeck SWOT Analysis
Table 119. H.Lundbeck Parkinson's Disease Drug Product and Services
Table 120. H.Lundbeck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Global Parkinson's Disease Drug Sales by Manufacturer (2018-2019) (K Doses)
Table 122. Global Parkinson's Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 123. Global Parkinson's Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 124. Global Parkinson's Disease Drug Sales Market Share by Regions (2015-2020)
Table 125. Global Parkinson's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 126. North America Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 127. North America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 128. North America Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 129. North America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 130. Europe Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 131. Europe Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 132. Europe Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. Asia-Pacific Parkinson's Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 134. Asia-Pacific Parkinson's Disease Drug Sales Market Share by Regions (2015-2020)
Table 135. Asia-Pacific Parkinson's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 136. South America Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 137. South America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 138. South America Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 139. South America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 140. Middle East & Africa Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 141. Middle East & Africa Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 144. Global Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 145. Global Parkinson's Disease Drug Sales Share by Type (2015-2020)
Table 146. Global Parkinson's Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 147. Global Parkinson's Disease Drug Revenue Share by Type (2015-2020)
Table 148. Global Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 149. Global Parkinson's Disease Drug Sales Share by Application (2015-2020)
Table 150. Global Parkinson's Disease Drug Sales Forecast by Regions (2021-2025) (K Doses)
Table 151. Global Parkinson's Disease Drug Market Share Forecast by Regions (2021-2025)
Table 152. Global Parkinson's Disease Drug Sales Forecast by Type (2021-2025) (K Doses)
Table 153. Global Parkinson's Disease Drug Market Share Forecast by Type (2021-2025)
Table 154. Global Parkinson's Disease Drug Sales Forecast by Application (2021-2025)
Table 155. Global Parkinson's Disease Drug Market Share Forecast by Application (2021-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Parkinson's Disease Drug Picture
Figure 2. Global Sales Market Share of Parkinson's Disease Drug by Type in 2019
Figure 3. Sinemet-CR Picture
Figure 4. Trastal Picture
Figure 5. Madopar Picture
Figure 6. COMT Inhibitor Picture
Figure 7. Other Picture
Figure 8. Parkinson's Disease Drug Sales Market Share by Application in 2018
Figure 9. Under 40 Years Old Picture
Figure 10. 40-65 Years Old Picture
Figure 11. Above 65 Years Old Picture
Figure 12. Global Parkinson's Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Parkinson's Disease Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Parkinson's Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Parkinson's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Parkinson's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 38. Global Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Parkinson's Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Parkinson's Disease Drug Revenue Market Share by Regions in 2018
Figure 41. North America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Parkinson's Disease Drug Sales Market Share by Countries in 2018
Figure 49. North America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Parkinson's Disease Drug Revenue Market Share by Countries in 2018
Figure 51. United States Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Canada Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Mexico Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. Europe Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Parkinson's Disease Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. UK Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. France Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Russia Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Italy Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Asia-Pacific Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Parkinson's Disease Drug Sales Market Share by Regions

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs